<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Healthblognews.com : Health News &#187; Fibromyalgia</title>
	<atom:link href="http://www.healthblognews.com/category/fibromyalgia/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.healthblognews.com</link>
	<description></description>
	<lastBuildDate>Sun, 14 Mar 2010 10:49:32 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Jazz Pharmaceuticals Announces FDA Acceptance Of Its New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia</title>
		<link>http://www.healthblognews.com/jazz-pharmaceuticals-announces-fda-acceptance-of-its-new-drug-application-for-jzp-6-sodium-oxybate-for-the-treatment-of-fibromyalgia/</link>
		<comments>http://www.healthblognews.com/jazz-pharmaceuticals-announces-fda-acceptance-of-its-new-drug-application-for-jzp-6-sodium-oxybate-for-the-treatment-of-fibromyalgia/#comments</comments>
		<pubDate>Sun, 14 Mar 2010 10:48:01 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/jazz-pharmaceuticals-announces-fda-acceptance-of-its-new-drug-application-for-jzp-6-sodium-oxybate-for-the-treatment-of-fibromyalgia/</guid>
		<description><![CDATA[Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that the U.S. Food and Drug Administration (FDA) has [...]]]></description>
			<content:encoded><![CDATA[<p>Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that the U.S. Food and <a href="http://www.onlinepharmacies.bz"target="_self"title="no prescription pharmacies" >Drug</a> Administration (FDA) has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia.  Based on a standard 10-month review, the target date for the FDA to complete its review of the NDA under the Prescription Drug User Fee Act (PDUFA) is October 11, 2010&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/jazz-pharmaceuticals-announces-fda-acceptance-of-its-new-drug-application-for-jzp-6-sodium-oxybate-for-the-treatment-of-fibromyalgia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jazz Pharmaceuticals And UCB Announce Positive Phase III Results For Sodium Oxybate In Fibromyalgia</title>
		<link>http://www.healthblognews.com/jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results-for-sodium-oxybate-in-fibromyalgia-2/</link>
		<comments>http://www.healthblognews.com/jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results-for-sodium-oxybate-in-fibromyalgia-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results-for-sodium-oxybate-in-fibromyalgia-2/</guid>
		<description><![CDATA[Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and UCB (Euronext Brussels: UCB) announced today positive preliminary top-line [...]]]></description>
			<content:encoded><![CDATA[<p>Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and UCB (Euronext Brussels: UCB) announced today positive preliminary top-line results from the first of two Phase III clinical trials of sodium oxybate (JZP-6) for the treatment of fibromyalgia&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results-for-sodium-oxybate-in-fibromyalgia-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Phase 3 Study Of Subcutaneous Relistor For Opioid-Induced Constipation For Chronic Non-Cancer Pain</title>
		<link>http://www.healthblognews.com/phase-3-study-of-subcutaneous-relistor-for-opioid-induced-constipation-for-chronic-non-cancer-pain-2/</link>
		<comments>http://www.healthblognews.com/phase-3-study-of-subcutaneous-relistor-for-opioid-induced-constipation-for-chronic-non-cancer-pain-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/phase-3-study-of-subcutaneous-relistor-for-opioid-induced-constipation-for-chronic-non-cancer-pain-2/</guid>
		<description><![CDATA[Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc&#8230;
]]></description>
			<content:encoded><![CDATA[<p>Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/phase-3-study-of-subcutaneous-relistor-for-opioid-induced-constipation-for-chronic-non-cancer-pain-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Forest Laboratories, Inc. And Cypress Bioscience, Inc. Announce Positive Results Of Phase III Study Of Milnacipran For The Management Of Fibromyalgia</title>
		<link>http://www.healthblognews.com/forest-laboratories-inc-and-cypress-bioscience-inc-announce-positive-results-of-phase-iii-study-of-milnacipran-for-the-management-of-fibromyalgia-2/</link>
		<comments>http://www.healthblognews.com/forest-laboratories-inc-and-cypress-bioscience-inc-announce-positive-results-of-phase-iii-study-of-milnacipran-for-the-management-of-fibromyalgia-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/forest-laboratories-inc-and-cypress-bioscience-inc-announce-positive-results-of-phase-iii-study-of-milnacipran-for-the-management-of-fibromyalgia-2/</guid>
		<description><![CDATA[Forest Laboratories, Inc. (NYSE:  FRX) and Cypress Bioscience, Inc. (Nasdaq:  CYPB)  announced [...]]]></description>
			<content:encoded><![CDATA[<p>Forest Laboratories, Inc. (NYSE:  FRX) and Cypress Bioscience, Inc. (Nasdaq:  CYPB)  announced positive top-line results from a 1,025 patient, multicenter, double-blind, placebo-controlled phase III study of milnacipran for the management of fibromyalgia&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/forest-laboratories-inc-and-cypress-bioscience-inc-announce-positive-results-of-phase-iii-study-of-milnacipran-for-the-management-of-fibromyalgia-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fibromyalgia Study Hopes To Decrease Pain, Other Symptoms</title>
		<link>http://www.healthblognews.com/fibromyalgia-study-hopes-to-decrease-pain-other-symptoms-2/</link>
		<comments>http://www.healthblognews.com/fibromyalgia-study-hopes-to-decrease-pain-other-symptoms-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/fibromyalgia-study-hopes-to-decrease-pain-other-symptoms-2/</guid>
		<description><![CDATA[Researchers at the Indiana University School of Medicine seek 200 people with fibromyalgia to determine [...]]]></description>
			<content:encoded><![CDATA[<p>Researchers at the Indiana University School of <a href="http://www.buyfioricet.bz"target="_self"title="buy fioricet" >Medicine</a> seek 200 people with fibromyalgia to determine if motivational reminder telephone calls can prompt patients to exercise more regularly.              Fibromyalgia is a disease that causes <a href="http://www.buytramadol.bz"target="_self"title="buy tramadol" >pain</a> in the muscles and tissue surrounding joints in nearly 5 percent of the population&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/fibromyalgia-study-hopes-to-decrease-pain-other-symptoms-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Fibromyalgia Drug &#8211; Savella(TM) (milnacipran HCl), A Selective Serotonin And Norepinephrine Dual Reuptake Inhibitor</title>
		<link>http://www.healthblognews.com/fda-approves-fibromyalgia-drug-savellatm-milnacipran-hcl-a-selective-serotonin-and-norepinephrine-dual-reuptake-inhibitor-2/</link>
		<comments>http://www.healthblognews.com/fda-approves-fibromyalgia-drug-savellatm-milnacipran-hcl-a-selective-serotonin-and-norepinephrine-dual-reuptake-inhibitor-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/fda-approves-fibromyalgia-drug-savellatm-milnacipran-hcl-a-selective-serotonin-and-norepinephrine-dual-reuptake-inhibitor-2/</guid>
		<description><![CDATA[Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that Savella(TM) [...]]]></description>
			<content:encoded><![CDATA[<p>Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) today announced that Savella(TM) (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and <a href="http://www.onlinepharmacies.bz"target="_self"title="no prescription pharmacies" >Drug</a> Administration (FDA) for the management of fibromyalgia&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/fda-approves-fibromyalgia-drug-savellatm-milnacipran-hcl-a-selective-serotonin-and-norepinephrine-dual-reuptake-inhibitor-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is It Just Pain&#8230;or Is It Fibromyalgia?</title>
		<link>http://www.healthblognews.com/is-it-just-pain-or-is-it-fibromyalgia-2/</link>
		<comments>http://www.healthblognews.com/is-it-just-pain-or-is-it-fibromyalgia-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/is-it-just-pain-or-is-it-fibromyalgia-2/</guid>
		<description><![CDATA[Months of constant pain, restless sleep and being drained of energy will make anyone seek [...]]]></description>
			<content:encoded><![CDATA[<p>Months of constant <a href="http://www.buytramadol.bz"target="_self"title="buy tramadol" >pain</a>, restless sleep and being drained of energy will make anyone seek help. Yet after the doctor has prescribed three different treatment regimens, the pain remains, the sleep is still restless and the body still lacks the proper energy to function. The patient becomes discouraged, as each attempt at healing the problem proves fruitless&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/is-it-just-pain-or-is-it-fibromyalgia-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pfizer Discontinues Development Of Two Phase 3 Compounds</title>
		<link>http://www.healthblognews.com/pfizer-discontinues-development-of-two-phase-3-compounds-2/</link>
		<comments>http://www.healthblognews.com/pfizer-discontinues-development-of-two-phase-3-compounds-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/pfizer-discontinues-development-of-two-phase-3-compounds-2/</guid>
		<description><![CDATA[Pfizer Inc announced today that, following a review of the development and commercial portfolios in [...]]]></description>
			<content:encoded><![CDATA[<p>Pfizer Inc announced today that, following a review of the development and commercial portfolios in the Primary Care Business Unit, it is terminating Phase 3 development programs for the investigational compounds esreboxetine for fibromyalgia and PD 332,334 for generalized anxiety disorder (GAD)&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/pfizer-discontinues-development-of-two-phase-3-compounds-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pilot Study Finds Inexpensive Drug Appears To Relieve Fibromyalgia Pain</title>
		<link>http://www.healthblognews.com/pilot-study-finds-inexpensive-drug-appears-to-relieve-fibromyalgia-pain-2/</link>
		<comments>http://www.healthblognews.com/pilot-study-finds-inexpensive-drug-appears-to-relieve-fibromyalgia-pain-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/pilot-study-finds-inexpensive-drug-appears-to-relieve-fibromyalgia-pain-2/</guid>
		<description><![CDATA[For Tara Campbell, the onset of her fibromyalgia began slowly with repeated sore throats, fevers [...]]]></description>
			<content:encoded><![CDATA[<p>For Tara Campbell, the onset of her fibromyalgia began slowly with repeated sore throats, fevers and fatigue. By the time she was diagnosed, a year later, she had become so debilitated by flulike symptoms and exhaustion that she often couldn&#8217;t get off the couch all day. &#8220;Fall, a year ago, I hit my very, very worst,&#8221; said Campbell, 39, of Walnut Creek, Calif&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/pilot-study-finds-inexpensive-drug-appears-to-relieve-fibromyalgia-pain-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Is Fibromyalgia? What Causes Fibromyalgia?</title>
		<link>http://www.healthblognews.com/what-is-fibromyalgia-what-causes-fibromyalgia-2/</link>
		<comments>http://www.healthblognews.com/what-is-fibromyalgia-what-causes-fibromyalgia-2/#comments</comments>
		<pubDate>Sun, 10 Jan 2010 15:53:27 +0000</pubDate>
		<dc:creator>Healthblognews.com</dc:creator>
				<category><![CDATA[Fibromyalgia]]></category>

		<guid isPermaLink="false">http://www.healthblognews.com/what-is-fibromyalgia-what-causes-fibromyalgia-2/</guid>
		<description><![CDATA[The word fibromyalgia comes from the Greek myos meaning &#8220;muscle&#8221;, Greek algos meaning &#8220;pain&#8220;, and [...]]]></description>
			<content:encoded><![CDATA[<p>The word fibromyalgia comes from the Greek myos meaning &#8220;muscle&#8221;, Greek algos meaning &#8220;<a href="http://www.buytramadol.bz"target="_self"title="buy tramadol" >pain</a>&#8220;, and New Latin fibro meaning &#8220;fibrous tissue&#8221;. According to MediLexicon&#8217;s medical dictionary, fibromyalgia is &#8220;A common syndrome of chronic widespread soft-tissue pain accompanied by weakness, fatigue, and sleep disturbances; the cause is unknown.&#8221; Fibromyalgia is a common and chronic disorder&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.healthblognews.com/what-is-fibromyalgia-what-causes-fibromyalgia-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
